Tuesday, November 10, 2026

Rocket Lab Q3: A $3.6B Backlog and the Neutron Debut Question

RKLBASTSSPCX
Why today:As of the 11/09 close, RKLB ranked #6 on the US heat list (score 64, discussion volume 3.4x normal), closing at $58.86, up 10.91%, then falling 5.2% after hours; peer ASTS rose 14.1% with discussion volume 4.4x normal. Rocket Lab's Q3 report after the close showed revenue of $268M, up 73% YoY and above the $257M consensus; backlog of about $3.6B, up 52% from the end of Q2; and Q4 revenue guidance of $270-290M. Why the stock reversed after hours is not yet verified.

The question this piece answers: Rocket Lab posted record revenue and a record backlog in Q3, so why did the stock fall after hours? When will the $3.6B backlog turn into revenue, and could the Neutron rocket, now slipped to 2027, slow that down? Market data is as of the Nov 9, 2026 close and after-hours session (ET). Financials come from the company's 8-K and 10-Q filed with the SEC on Nov 9.

1. Up 11% in the day session, down after hours: what happened

During regular trading on Monday, Nov 9, Rocket Lab (RKLB) closed at $58.86, up 10.91% on the day. The company reported Q3 results after the close, and the stock reversed: our snapshot showed it 5.23% below the close in after-hours trading. Space stocks were strong across the board that day. AST SpaceMobile (ASTS) closed up 14.1% and SpaceX (SPCX) closed up 5.81%.

On its face, the report is hard to read as bad news. Q3 revenue was $268M, up 73% year on year and above the $257M analysts expected. Backlog reached about $3.6B, up 52% from the end of Q2. Q4 revenue guidance was $270–290M, with a $280M midpoint, above the prior consensus of $265M. The company also reported positive GAAP operating cash flow for the first time, at $7.2M.

Three things combined to push the stock down: the per-share loss missed estimates; the stock had already risen about 28% in the two sessions before the print; and Neutron's first launch is still only "no earlier than 2027." Below, we first explain how the business makes money, then take the three core questions one at a time.

Retail attention jumped. On the Aya US heat ranking (Nov 9 close), RKLB scored 64 and ranked #6, with discussion volume 3.4x normal. Among self-tagged posts, 66% were bullish and 34% bearish. ASTS ranked #8, with discussion volume 4.4x normal.

2. Rocket Lab now earns mainly from satellites, not rockets

Many people still think of Rocket Lab as a small-rocket company. Its Electron rocket had completed 93 successful missions as of Sept 30, and in 2025 it was the world's second most frequently launched orbital rocket. But the revenue mix shifted a long time ago.

In Q3, the Space Systems segment brought in $214.8M, or 80.2% of revenue, up 88.1% year on year. This segment covers satellite buses, satellite components, solar cells, optical payloads and similar products. Launch Services brought in only $53.1M, up 29.8% year on year and 19.1% from Q2. Over the past few years the company has bought SolAero (solar cells), GEOST (electro-optical payloads), Mynaric (laser communications) and Motiv (space robotics), building up the ability to supply rockets, satellites and components together. Of the 12 Rocket Lab-built spacecraft launched this quarter, eight were buses for Globalstar's direct-to-device constellation.

Rocket Lab's growth comes mainly from Space Systems

The chart shows that most of the revenue added over the past year came from Space Systems. Launch fell from the prior quarter in Q2 and recovered in Q3, but it is still small.

This matters for what follows. Space Systems is mostly large, multi-year work that is recognized as revenue as the project progresses. Launch revenue comes one launch at a time. So the roughly $1B of launch contracts and $470M of Space Systems contracts signed in Q3 will turn into revenue on very different timelines.

3. Core question 1: When will the $3.6B backlog become revenue?

Conclusion: About a third should be recognized within 12 months and the other two-thirds after that. Most of the newly signed Neutron launch contracts can't become revenue until the rocket is actually flying.

The evidence is in the 10-Q. At Sept 30, backlog was $3.57B. About 33% is expected to be recognized within 12 months and 67% beyond that. That works out to roughly $1.18B in the next year and $2.39B after. For comparison, consensus for full-year 2027 revenue is about $1.33B (yfinance, average of 19 analysts). So the backlog due within 12 months covers roughly 89% of next year's expected revenue. The two time windows don't line up exactly: the backlog figure covers Oct 2026 to Sept 2027, while the consensus covers calendar 2027. Treat this as a rough check, not a precise match. It does show that next year's revenue forecast isn't built on contracts that haven't been signed yet.

The backlog growth also checks out. Backlog rose by a net $1.21B this quarter ($3.57B minus $2.36B). The company signed about $1B of launch contracts and $470M of Space Systems contracts, and recognized $268M of revenue. New signings minus recognized revenue roughly equals the net increase, so nothing looks off in how backlog is counted. Contracted launches now total 117, a company record.

The catch is that most of the backlog is far out. More than $515M of the new $1B in launch contracts was for Neutron. Neutron won't fly before 2027, and it will need time after its debut to reach a steady launch rate, so these contracts very likely sit in the 67% recognized after 12 months. The company doesn't break the 12-month split down by product, so this is our inference from the launch schedule, not a disclosed figure. Also, 42% of revenue in the first nine months came from government customers, and government funding and acceptance schedules affect how fast backlog converts.

4. Core question 2: What are the risks to Neutron's debut and its 16 contracted missions?

Conclusion: In the near term, losing the 16 Neutron contracts looks unlikely, because launch capacity is getting tight. The real risk is timing: each quarter the debut slips pushes that revenue back a quarter, and the stock has already been marked down for the uncertainty around the debut.

Start with the timeline. On the Q2 call in August, management said first-flight hardware should reach the pad in Q4, but that "the year-end launch window is narrowing." After the close on Oct 14, CEO Peter Beck said in a video that inspections had found voids (air pockets) inside the carbon-composite dome of the first-stage propellant tank, and the debut was moving to 2027. In his words, the voids "don't necessarily mean that the dome would fail in flight," but "possible success isn't our standard." The stock then fell from $68.21 on Oct 9 to $50.84 on Oct 16, down 25.5% in a week. This report only says "no earlier than 2027," with no specific quarter. It stresses that assembly, testing and delivery of first-flight hardware to Launch Complex 3 (LC-3) are continuing.

The stock stepped down after the Neutron delay, then bounced hard before earning

The chart shows two things. The Oct 14–16 drop lines up with the Neutron delay news. And from Nov 5 to Nov 9 the stock climbed from $45.99 back to $58.86, so part of the good news was already priced in before the report.

Why do the contracts look unlikely to walk in the near term? There are three pieces of evidence, all from outside the company:

  1. This quarter Rocket Lab raised the base price for several Neutron missions from $55M to $70M, citing tightening industry launch capacity. Raising prices before the first flight suggests customers are lining up.
  2. The same day, ASTS said in its report that BlueBirds 14–16 reached Cape Canaveral in September but are still "awaiting SpaceX launch date confirmation." ASTS also announced it will build its own 20-ton reusable rocket, Blacklift, which it targets for use from late 2028. A satellite company deciding to build its own rocket is a sign that medium-lift capacity is genuinely short.
  3. In the US, SpaceX's Falcon 9 is essentially the only medium-lift reusable rocket flying on a regular schedule. Customers who want a second supplier don't have many options.

This evidence only shows that customers are willing to wait, not that they will wait forever. The company hasn't disclosed the cancellation terms or delay penalties in its Neutron contracts. At a rough $55–70M per mission, the 16 missions are worth about $0.88–1.12B, or roughly a quarter to a third of total backlog. That is our estimate, not a company figure. If the first flight fails, or slips past the second half of 2027, both the timing of that revenue and customers' patience will be tested. New rockets often fail on their first flight; that risk applies to the whole industry.

5. Core question 3: Margins, cash flow and the Iridium deal

Conclusion: Gross margin fell from Q2's high but beat the company's own guidance. Operating cash flow turned positive for the first time, but mostly thanks to customer prepayments and interest income. The bigger financial variable is the Iridium acquisition and the share dilution that comes with it.

Gross margin is how much of each $1 of revenue is left after direct costs. Rocket Lab's Q3 GAAP gross margin was 33.6%, below Q2's 36.1% and the year-earlier 36.9%, but above the 29–31% the company guided at the start of the quarter. Non-GAAP gross margin, which excludes stock compensation and some other items, was 38.4%, versus 41.5% in Q2. Q4 guidance calls for GAAP gross margin of 34–36% and non-GAAP of 39–41%, so the company expects a rebound. Margin swings mainly reflect product mix. The company doesn't disclose margins by segment, so we can't tell whether Space Systems earns higher or lower margins than Launch.

Metric2026Q22026Q32026Q4 guide
GAAP gross margin36.1%33.6%34–36%
Non-GAAP gross margin41.5%38.4%39–41%
Adj. EBITDA (USD M)-8.8-18.0-14 to -20
GAAP operating cash flow (USD M)—+7.2Not guided

Now cash flow. Q3 operating cash flow was $7.15M and capex about $31.07M, so free cash flow was about -$23.92M, still an outflow. Operating cash flow turned positive largely because of two items. The first is customer prepayments: contract liabilities rose from $195M at the start of the year to $424M. The second is interest income of $28.6M in the quarter, earned on the company's large cash balance. Neither means the core business is now making money. Meanwhile, receivables, contract assets and inventory are absorbing a lot of working capital, which is normal when orders are growing this fast.

The EPS miss came mostly from a one-time item. Q3 GAAP loss per share was $0.12, against an expected $0.07. But the $79.7M net loss included a $27.3M loss on extinguishment of convertible notes, which is a one-time, non-operating charge. Excluding it, the net loss was about $52.4M, or roughly $0.08 per share on the weighted share count, about a cent from the estimate. The year-on-year comparison is also distorted: the year-ago quarter had a $41.1M income tax benefit, while this quarter had a $3.5M tax expense. So the "loss widens sharply" headline overstates how much operations actually deteriorated.

The Iridium deal is the bigger variable. Under the terms in the 10-Q, Iridium shareholders get $27 in cash per share plus some RKLB stock. The stock portion uses a sliding ratio: when RKLB trades below $67.50, it is fixed at 0.40 RKLB shares per Iridium share. At today's $58.86, that values each Iridium share at about $50.54. On the Q2 call, management said Iridium has 66 satellites in orbit, more than 2.5 million subscribers and over $870M in annual revenue, close to Rocket Lab's own expected revenue for all of 2026. The deal still needs approval from the US Federal Communications Commission (FCC) and some foreign regulators, and is expected to close in 2027. To fund it, the company raised about $3.91B in the first nine months through at-the-market (ATM) offerings, meaning it sold new shares into the market in batches. It ended the quarter with about $4.70B in cash and marketable securities. The cost is dilution: Q3 weighted shares rose 23.4% year on year, and the company expects 681M basic shares in Q4, including about 41M preferred shares. After the deal closes, revenue scale and profit mix will change significantly, so today's margin figures won't be directly comparable afterward.

6. What the market is betting on: valuation against SpaceX and AST SpaceMobile

The short answer: after six months of declines, space stock valuations have come down a lot, but they are still high relative to revenue. Today's price mostly reflects expectations for 2027, such as whether Neutron flies successfully and whether Iridium is integrated smoothly, not this year's profits.

In numbers: RKLB's market cap at the close was about $37.6B (yfinance). Subtracting about $4.70B of cash and marketable securities gives an enterprise value of about $33.1B. Enterprise value (EV) is roughly what it would cost to buy the whole company after netting out the cash on its books. That is about 37.5x trailing-12-month revenue ($882M), or about 24.9x 2027 consensus revenue. For comparison, ASTS's EV on yfinance numbers is about 17.9x its 2027 expected revenue. SPCX has a market cap of about $1.93 trillion and an EV of about 55.3x trailing revenue.

Three space stocks: EV-to-revenue multiples

On trailing revenue, RKLB is the "cheapest" of the three. On 2027 expected revenue, ASTS is lower. That is because the market expects ASTS revenue to grow faster next year, but analysts disagree far more: 2027 revenue forecasts for ASTS range from $345M to $911M.

The price action shows some of the froth is already gone. RKLB is about 61% below its $151 all-time high, ASTS about 72.4% below its peak, and SPCX about 37% below its post-IPO high.

So is the valuation stretched? There are two ways to look at it:

  • What supports it: about $1.18B of backlog due within 12 months already roughly covers next year's revenue forecast, and about $4.70B of cash at quarter-end is enough to fund R&D and the acquisition. The sell side is still broadly bullish: the 20 analysts tracked by yfinance have an average price target of $102.15, with a low of $64 and a high of $150.
  • The risk that it is stretched: a forward EV-to-revenue of nearly 25x means the market assumes years of fast growth and an eventual swing to profit. But the company still has negative adjusted EBITDA and guides to a Q4 loss of $14–20M. Several things have to go right at once to justify the valuation: Neutron flies successfully and ramps quickly, Iridium is integrated smoothly, and new share issuance doesn't keep diluting shareholders heavily. A problem with any one of them could trigger a re-rating.

One more point: the Nov 9 sector rally wasn't purely about fundamentals. That day ASTS announced a joint venture with Japan's Rakuten that could receive about ¥148 billion of Japanese government support, and NASA had announced the winners of its Commercial Lunar Payload Services (CLPS) program, with a $10B ceiling. Rocket Lab was not on NASA's list but still rallied hard, which suggests much of that day's move came from sector sentiment.

7. What to watch next

  • Neutron first-flight hardware reaching the pad and starting static-fire testing: this is the most direct early signal of a launch date. A specific debut quarter or the start of full-vehicle testing would reduce uncertainty about the first flight. A new materials or manufacturing problem would push the backlog timeline out further.
  • FCC review of the Iridium deal: closing is expected in 2027. Any delay or added conditions would affect Rocket Lab's 2027 revenue base. Note that below $67.50 the exchange ratio is fixed at 0.40 shares: a lower RKLB price means less stock value paid to Iridium holders, but the same dilution for existing RKLB shareholders.
  • Q4 2026 results (likely late February 2027, inferred from last year's 10-K filing on Feb 26): three things to check: whether revenue lands within the $270–290M guide, whether GAAP gross margin gets back into the 34–36% range, and whether operating cash flow stays positive.
  • The share of backlog due within 12 months: currently 33%. If it rises as the Neutron schedule becomes clearer, backlog is starting to convert faster. If it keeps falling, more and more of the new orders are long-dated.
  • Capacity signals from other companies: when SpaceX gives ASTS a launch date for BlueBirds 14–16, and the ASTS mission on Blue Origin expected in early Q1 2027. These test whether launch capacity is really as tight as claimed, which is the basis for Neutron's price increase.

Conclusion

Rocket Lab's Q3 beat expectations on revenue, backlog and guidance. The EPS miss came mostly from a $27.3M one-time debt extinguishment loss, and operations deteriorated less than the headline suggests. The after-hours drop is more likely the result of two things together: profit-taking after a roughly 28% run-up in the two days before the report, and Neutron still lacking a firm launch date. About a third of the $3.6B backlog should turn into revenue within a year, enough to support next year's forecast. But Neutron's 16 missions and the Iridium deal decide how much the company can grow after 2027. At about 24.9x 2027 expected revenue, the valuation already assumes both go well. What investors need to watch next is whether those expectations are met, one by one, over the coming year.


Appendix: Data and Sources

A. Key financials (USD millions unless noted)

Item2025Q32026Q22026Q3Source / formula
Total revenue155.08234.07267.838-K / Q2 8-K
Space Systems revenue114.2189.5214.810-Q; Q2 call summary
Launch Services revenue40.944.653.1Same
GAAP gross profit57.3184.5890.078-K
GAAP gross margin36.9%36.1%33.6%Gross profit / revenue
Non-GAAP gross margin—41.5%38.4%Company
Adj. EBITDA-26.3-8.8-18.0Company
Net loss-18.26—-79.688-K
Loss on debt extinguishment——-27.268-K
Weighted shares (M)528.7—652.38-K
Backlog (USD B)—2.363.57Company

Derived calculations:

  • Revenue YoY = 267.834/155.080 − 1 = 72.7%
  • Space Systems share = 214.8/267.8 = 80.2%; Space Systems YoY = 214.8/114.2 − 1 = 88.1%; Launch YoY = 53.1/40.9 − 1 = 29.8%; Launch QoQ = 53.1/44.6 − 1 = 19.1%
  • Q3 operating cash flow = 9M −127.254 − 1H (−134.407) = +7.153; Q3 capex = 84.185 − 53.112 = 31.073; Q3 FCF = 7.153 − 31.073 = −23.92
  • Net loss excluding extinguishment = −79.677 + 27.259 = −52.418; per share = 52.418/652.264 ≈ $0.080
  • Weighted shares YoY = 652.264/528.726 − 1 = 23.4%
  • Backlog due within 12 months ≈ 35.7 × 33% ≈ $1.18B; beyond 12 months = 35.7 − 11.8 = $2.39B; coverage of 2027E revenue = 11.8/13.31 ≈ 88.7%
  • Net backlog increase in the quarter = 35.7 − 23.6 = $1.21B
  • Q4 guide midpoint QoQ = 280/267.8 − 1 = 4.6%
  • Iridium consideration per share (RKLB at $58.86) = 27 + 0.40 × 58.86 = $50.54

B. Valuation comparison (Nov 9, 2026 close)

MetricRKLBASTSSPCX
Close (USD)58.8636.89142.07
Market cap (USD B, yfinance)37.6414.361,929.5
EV (USD B)33.07 (calculated)10.90 (yfinance)1,772.9 (yfinance)
EV / trailing 12M revenue37.5x94.5x55.3x
EV / 2027E revenue24.9x17.9xn/a (forecasts range $71.7B–$290.1B, too wide)
vs. all-time high−61.0%−72.4%−37.0%
Avg. analyst target (USD)102.15 (20)74.68 (12)255.06 (37)

Formulas: RKLB EV = market cap 37.636 − cash and securities 4.704 + debt 0.134 = 33.07. TTM revenue = 4Q25 179.652 + 9M26 702.248 = 881.9 (USD M). EV/TTM = 33.07/0.8819. EV/2027E = 33.07/1.3306. ASTS EV/2027E = 10.901/0.6091. ASTS and SPCX EV and trailing multiples come straight from yfinance, whose cash figures may not yet reflect the latest quarter.

C. Timeline

Date (ET)Event
Late May 2026RKLB hits its all-time high of $151
Jun 12, 2026SpaceX (SPCX) begins trading
Aug 10, 2026Q2 results: revenue $234M, backlog $2.36B; Iridium acquisition announced; management says Neutron's "year-end window is narrowing"
Oct 14, 2026After the close, company discloses voids in Neutron tank dome; debut pushed to 2027
Oct 15/16, 2026RKLB closes at $55.25 / $50.84
Nov 5, 2026RKLB closes at $45.99 (low of this move)
Nov 7, 2026NASA names CLPS winners under a $10B ceiling (RKLB not included)
Nov 9, 2026ASTS announces Rakuten JV in Japan; RKLB closes +10.91%, reports Q3 after the close and reverses lower; ASTS reports Q3 the same evening (revenue $42.3M; announces its own Blacklift rocket)

D. Aya heat data (US heat ranking, Nov 9, 2026 close)

RankTickerHeatDiscussion vs. normalBull/Bear (self-tagged posts)
4SPCX641.0x92% / 8% (38)
6RKLB643.4x66% / 34% (29)
8ASTS634.4x73% / 27% (26)

E. Market commentary

  • Investing.com (Nov 9): attributed the after-hours drop to "an earnings miss despite a revenue beat"; shares were down 3.8% after hours at the time.
  • TipRanks (Nov 9): said Neutron being "pushed into 2027" raised concerns about execution; TipRanks' average analyst target is $99.19 (15 Buy, 3 Hold).
  • StockStory (Nov 9): called the Q4 revenue guidance, 5.1% above consensus at the midpoint, "surprisingly strong."
  • 24/7 Wall St. (Nov 9): described the sector-wide rally as a rebound from the prior week's post-election selloff.
  • We were unable to pull live X (Twitter) data for this piece, so no KOL views are quoted.

F. Sources

For information and research discussion only. Not investment advice.

<!-- AYA_PODCAST -->

🎙️ Podcast script (Chinese, ~20 min, 泓观阳略): read it here

AI-generated by Aya Research from public data and disclosures, for information and research purposes only. Not investment advice.